Thrombospondin-1 derived from APCs regulates their capacity for allosensitization

Journal of Immunology

Volumn 185, Issue 8, 2010, Pages 4691-4697

  Saban, Daniel R ^a,b   Bock, Felix ^c   Chauhan, Sunil K ^a,b   Masli, Sharmila ^a,b   Dana, Reza ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; THROMBOSPONDIN 1;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA TRANSPLANTATION; GRAFT REJECTION; INFLAMMATION; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL SEPARATION; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MIXED LYMPHOCYTE CULTURE; NEUTROPHIL CHEMOTAXIS;

ANIMALS; ANTIGEN-PRESENTING CELLS; CELL SEPARATION; CHEMOTAXIS, LEUKOCYTE; CORNEAL TRANSPLANTATION; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; THROMBOSPONDIN 1; TRANSPLANTATION IMMUNOLOGY;

EID: 78049511289     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001133     Document Type: Article

References (32)

1. Adams, J. C., and J. Lawler. 2004. The thrombospondins. Int. J. Biochem. Cell Biol. 36:961-968.
2. Sarfati, M., G. Fortin, M. Raymond, and S. Susin. 2008. CD47 in the immune response: role of thrombospondin and SIRP-alpha reverse signaling. Curr. Drug Targets 9:842-850.
3. Crawford, S. E., V. Stellmach, J. E. Murphy-Ullrich, S. M. Ribeiro, J. Lawler, R. O. Hynes, G. P. Boivin, and N. Bouck. 1998. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93:1159-1170.
4. Yehualaeshet, T., R. O'Connor, J. Green-Johnson, S. Mai, R. Silverstein, J. E. Murphy-Ullrich, and N. Khalil. 1999. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol. 155:841-851.
5. Masli, S., B. Turpie, and J. W. Streilein. 2006. Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells. Int. Immunol. 18:689-699.
6. Demeure, C. E., H. Tanaka, V. Mateo, M. Rubio, G. Delespesse, and M. Sarfati. 2000. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. 164:2193-2199.
7. Marteau, F., N. S. Gonzalez, D. Communi, M. Goldman, J. M. Boeynaems, and D. Communi. 2005. Thrombospondin-1 and indoleamine 2, 3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106:3860-3866.
8. Doyen, V., M. Rubio, D. Braun, T. Nakajima, J. Abe, H. Saito, G. Delespesse, and M. Sarfati. 2003. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J. Exp. Med. 198:1277-1283.
9. Tabib, A., A. Krispin, U. Trahtemberg, I. Verbovetski, M. Lebendiker, T. Danieli, and D. Mevorach. 2009. Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells. PLoS One. 4: e6840.
10. Kukreja, A., S. Radfar, B. H. Sun, K. Insogna, and M. V. Dhodapkar. 2009. Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease. Blood 114:3413-3421.
11. Cursiefen, C., S. Masli, T. F. Ng, M. R. Dana, P. Bornstein, J. Lawler, and J. W. Streilein. 2004. Roles of thrombospondin-1 and-2 in regulating corneal and iris angiogenesis. Invest. Ophthalmol. Vis. Sci. 45:1117-1124.
12. Sekiyama, E., T. Nakamura, L. J. Cooper, S. Kawasaki, J. Hamuro, N. J. Fullwood, and S. Kinoshita. 2006. Unique distribution of thrombospondin-1 in human ocular surface epithelium. Invest. Ophthalmol. Vis. Sci. 47:1352-1358. (Pubitemid 46780741)
13. Huq, S., Y. Liu, G. Benichou, and M. R. Dana. 2004. Relevance of the direct pathway of sensitization in corneal transplantation is dictated by the graft bed microenvironment. J. Immunol. 173:4464-4469.
14. Dastjerdi, M. H., D. R. Saban, A. Okanobo, N. Nallasamy, Z. Sadrai, S. K. Chauhan, A. R. Hajrasouliha, and R. Dana. 2010. Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest. Ophthalmol. Vis. Sci. 51:2411-2417.
15. Saban, D. R., S. K. Chauhan, X. Zhang, J. El Annan, Y. Jin, and R. Dana. 2009. 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. Am. J. Transplant. 9:473-482.
16. Shen, L., Y. Jin, G. J. Freeman, A. H. Sharpe, and M. R. Dana. 2007. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival. J. Immunol. 179:3672-3679.
17. Benichou, G., A. Valujskikh, and P. S. Heeger. 1999. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 162:352-358.
18. Dekaris, I., S. N. Zhu, and M. R. Dana. 1999. TNF-alpha regulates corneal Langerhans cell migration. J. Immunol. 162:4235-4239.
19. Boisgérault, F., Y. Liu, N. Anosova, R. Dana, and G. Benichou. 2009. Differential roles of direct and indirect allorecognition pathways in the rejection of skin and corneal transplants. Transplantation 87:16-23.
20. Uno, K., H. Hayashi, M. Kuroki, H. Uchida, Y. Yamauchi, M. Kuroki, and K. Oshima. 2004. Thrombospondin-1 accelerates wound healing of corneal epithelia. Biochem. Biophys. Res. Commun. 315:928-934.
21. Zhu, S., I. Dekaris, G. Duncker, and M. R. Dana. 1999. Early expression of proinflammatory cytokines interleukin-1 and tumor necrosis factor-alpha after corneal transplantation. J. Interferon Cytokine Res. 19:661-669.
22. Lutz, M. B., and G. Schuler. 2002. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 23:445-449.
23. Morelli, A. E., and A. W. Thomson. 2007. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7:610-621.
24. Förster, R., A. C. Davalos-Misslitz, and A. Rot. 2008. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8:362-371.
25. Collins, M. K., C. S. Tay, and A. Erlebacher. 2009. Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal/fetal interface in mice. J. Clin. Invest. 119:2062-2073.
26. Liu, Y., P. Hamrah, Q. Zhang, A. W. Taylor, and M. R. Dana. 2002. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts. J. Exp. Med. 195:259-268.
27. Chauhan, S. K., D. R. Saban, H. K. Lee, and R. Dana. 2009. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J. Immunol. 182:148-153.
28. Bouguermouh, S., V. Q. Van, J. Martel, P. Gautier, M. Rubio, and M. Sarfati. 2008. CD47 expression on T cell is a self-control negative regulator of type 1 immune response. J. Immunol. 180:8073-8082.
29. Grimbert, P., S. Bouguermouh, N. Baba, T. Nakajima, Z. Allakhverdi, D. Braun, H. Saito, M. Rubio, G. Delespesse, and M. Sarfati. 2006. Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25-T cells in response to inflammation. J. Immunol. 177:3534-3541.
30. Olerud, J., M. Johansson, J. Lawler, N. Welsh, and P. O. Carlsson. 2008. Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets. Diabetes 57:1870-1877.
31. Isenberg, J. S., L. K. Pappan, M. J. Romeo, M. Abu-Asab, M. Tsokos, D. A. Wink, W. A. Frazier, and D. D. Roberts. 2008. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann. Surg. 247:180-190.
32. Dietrich, T., F. Bock, D. Yuen, D. Hos, B. O. Bachmann, G. Zahn, S. Wiegand, L. Chen, and C. Cursiefen. 2010. Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J. Immunol. 184:535-539.